

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | branched-chain amino acid catabolic process (GO:0009083) | 5.41730374 |
| 2 | DNA deamination (GO:0045006) | 4.94450076 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 4.84720474 |
| 4 | branched-chain amino acid metabolic process (GO:0009081) | 4.47818976 |
| 5 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.34926448 |
| 6 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.33068422 |
| 7 | purine nucleobase biosynthetic process (GO:0009113) | 4.28011969 |
| 8 | DNA strand elongation (GO:0022616) | 4.26530787 |
| 9 | nucleobase biosynthetic process (GO:0046112) | 4.19259707 |
| 10 | proteasome assembly (GO:0043248) | 4.16687773 |
| 11 | amino acid salvage (GO:0043102) | 4.16633784 |
| 12 | L-methionine salvage (GO:0071267) | 4.16633784 |
| 13 | L-methionine biosynthetic process (GO:0071265) | 4.16633784 |
| 14 | protein complex biogenesis (GO:0070271) | 4.13297744 |
| 15 | valine metabolic process (GO:0006573) | 4.13260252 |
| 16 | metallo-sulfur cluster assembly (GO:0031163) | 4.12746413 |
| 17 | iron-sulfur cluster assembly (GO:0016226) | 4.12746413 |
| 18 | DNA replication initiation (GO:0006270) | 4.07774827 |
| 19 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.93438157 |
| 20 | NADH dehydrogenase complex assembly (GO:0010257) | 3.93438157 |
| 21 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.93438157 |
| 22 | ubiquinone biosynthetic process (GO:0006744) | 3.92494041 |
| 23 | respiratory chain complex IV assembly (GO:0008535) | 3.88716801 |
| 24 | mannosylation (GO:0097502) | 3.86692816 |
| 25 | telomere maintenance via recombination (GO:0000722) | 3.84837181 |
| 26 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.82260907 |
| 27 | cytochrome complex assembly (GO:0017004) | 3.81620849 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.81552713 |
| 29 | DNA replication checkpoint (GO:0000076) | 3.76435383 |
| 30 | formation of translation preinitiation complex (GO:0001731) | 3.69901497 |
| 31 | ubiquinone metabolic process (GO:0006743) | 3.66298217 |
| 32 | ribosome biogenesis (GO:0042254) | 3.63713831 |
| 33 | protein-cofactor linkage (GO:0018065) | 3.63521252 |
| 34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.58584710 |
| 35 | ribosome assembly (GO:0042255) | 3.57076436 |
| 36 | IMP biosynthetic process (GO:0006188) | 3.54269605 |
| 37 | rRNA modification (GO:0000154) | 3.49175853 |
| 38 | mitotic recombination (GO:0006312) | 3.48789831 |
| 39 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.47175543 |
| 40 | maturation of SSU-rRNA (GO:0030490) | 3.45996651 |
| 41 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.44818222 |
| 42 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.44117020 |
| 43 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.40908323 |
| 44 | response to pheromone (GO:0019236) | 3.40298184 |
| 45 | viral mRNA export from host cell nucleus (GO:0046784) | 3.38838941 |
| 46 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.36741253 |
| 47 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.34703877 |
| 48 | telomere maintenance via telomere lengthening (GO:0010833) | 3.33512512 |
| 49 | pseudouridine synthesis (GO:0001522) | 3.30113249 |
| 50 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.29645369 |
| 51 | cullin deneddylation (GO:0010388) | 3.26481793 |
| 52 | CENP-A containing nucleosome assembly (GO:0034080) | 3.25977440 |
| 53 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.24111337 |
| 54 | negative regulation of ligase activity (GO:0051352) | 3.24111337 |
| 55 | spliceosomal snRNP assembly (GO:0000387) | 3.23555261 |
| 56 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.20393303 |
| 57 | ribosomal large subunit biogenesis (GO:0042273) | 3.19568809 |
| 58 | folic acid metabolic process (GO:0046655) | 3.18687170 |
| 59 | protein deneddylation (GO:0000338) | 3.16425353 |
| 60 | mitotic metaphase plate congression (GO:0007080) | 3.13774535 |
| 61 | chromatin remodeling at centromere (GO:0031055) | 3.12646389 |
| 62 | methionine biosynthetic process (GO:0009086) | 3.12074210 |
| 63 | quinone biosynthetic process (GO:1901663) | 3.11907479 |
| 64 | termination of RNA polymerase III transcription (GO:0006386) | 3.10839555 |
| 65 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.10839555 |
| 66 | oxidative phosphorylation (GO:0006119) | 3.10276451 |
| 67 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.09848717 |
| 68 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.09255190 |
| 69 | IMP metabolic process (GO:0046040) | 3.08981930 |
| 70 | ATP synthesis coupled proton transport (GO:0015986) | 3.08814151 |
| 71 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.08814151 |
| 72 | inositol phosphate catabolic process (GO:0071545) | 3.08560896 |
| 73 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.07455678 |
| 74 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.06950776 |
| 75 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.05998256 |
| 76 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.02776021 |
| 77 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.02776021 |
| 78 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.02776021 |
| 79 | GPI anchor metabolic process (GO:0006505) | 3.02706921 |
| 80 | rRNA processing (GO:0006364) | 3.01606997 |
| 81 | viral transcription (GO:0019083) | 3.01154818 |
| 82 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.01030285 |
| 83 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.01030285 |
| 84 | GPI anchor biosynthetic process (GO:0006506) | 3.00918190 |
| 85 | translational termination (GO:0006415) | 2.99486618 |
| 86 | GMP metabolic process (GO:0046037) | 2.98734813 |
| 87 | translational elongation (GO:0006414) | 2.98315812 |
| 88 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97824630 |
| 89 | DNA unwinding involved in DNA replication (GO:0006268) | 2.96016389 |
| 90 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.94726733 |
| 91 | ribosomal small subunit biogenesis (GO:0042274) | 2.94585519 |
| 92 | regulation of mitochondrial translation (GO:0070129) | 2.94323460 |
| 93 | NADH metabolic process (GO:0006734) | 2.94254102 |
| 94 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.93310742 |
| 95 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.93310742 |
| 96 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.93120108 |
| 97 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.92798726 |
| 98 | DNA replication-independent nucleosome organization (GO:0034724) | 2.92798726 |
| 99 | cellular component biogenesis (GO:0044085) | 2.92632609 |
| 100 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.92285657 |
| 101 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.91798305 |
| 102 | cell cycle G1/S phase transition (GO:0044843) | 2.91798305 |
| 103 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.90823887 |
| 104 | rRNA methylation (GO:0031167) | 2.90795631 |
| 105 | rRNA metabolic process (GO:0016072) | 2.90635035 |
| 106 | translation (GO:0006412) | 2.89730706 |
| 107 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.89633065 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.89249319 |
| 109 | 7-methylguanosine mRNA capping (GO:0006370) | 2.86288143 |
| 110 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.85231633 |
| 111 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.85030787 |
| 112 | methionine metabolic process (GO:0006555) | 2.84209660 |
| 113 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.83782593 |
| 114 | positive regulation of ligase activity (GO:0051351) | 2.83142387 |
| 115 | autophagic vacuole fusion (GO:0000046) | 2.83117484 |
| 116 | protein targeting to mitochondrion (GO:0006626) | 2.82846830 |
| 117 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.82424382 |
| 118 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.82424382 |
| 119 | C-terminal protein lipidation (GO:0006501) | 2.82163038 |
| 120 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.81702021 |
| 121 | deoxyribonucleotide catabolic process (GO:0009264) | 2.80985625 |
| 122 | translational initiation (GO:0006413) | 2.80657666 |
| 123 | 7-methylguanosine RNA capping (GO:0009452) | 2.80139168 |
| 124 | RNA capping (GO:0036260) | 2.80139168 |
| 125 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.79942057 |
| 126 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.79942057 |
| 127 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.79601550 |
| 128 | metaphase plate congression (GO:0051310) | 2.79414150 |
| 129 | C-terminal protein amino acid modification (GO:0018410) | 2.79209790 |
| 130 | mitochondrial RNA metabolic process (GO:0000959) | 2.79122869 |
| 131 | DNA integration (GO:0015074) | 2.78688559 |
| 132 | mitotic nuclear envelope disassembly (GO:0007077) | 2.77237503 |
| 133 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.76076819 |
| 134 | tricarboxylic acid cycle (GO:0006099) | 2.76062850 |
| 135 | cellular ketone body metabolic process (GO:0046950) | 2.74634006 |
| 136 | positive regulation of mitochondrial fission (GO:0090141) | 2.74468980 |
| 137 | termination of RNA polymerase I transcription (GO:0006363) | 2.74008308 |
| 138 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.73198628 |
| 139 | mitochondrial DNA replication (GO:0006264) | 2.73132099 |
| 140 | telomere organization (GO:0032200) | 2.73087381 |
| 141 | adenosine metabolic process (GO:0046085) | 2.72126178 |
| 142 | telomere maintenance (GO:0000723) | 2.71980292 |
| 143 | transcription from RNA polymerase I promoter (GO:0006360) | 2.71775097 |
| 144 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.71140185 |
| 145 | postreplication repair (GO:0006301) | 2.70731039 |
| 146 | establishment of protein localization to mitochondrion (GO:0072655) | 2.70683762 |
| 147 | peptidyl-histidine modification (GO:0018202) | 2.70504489 |
| 148 | respiratory electron transport chain (GO:0022904) | 2.70279603 |
| 149 | DNA-dependent DNA replication (GO:0006261) | 2.70190751 |
| 150 | maturation of 5.8S rRNA (GO:0000460) | 2.70144256 |
| 151 | tRNA methylation (GO:0030488) | 2.70024836 |
| 152 | purine-containing compound salvage (GO:0043101) | 2.69728056 |
| 153 | electron transport chain (GO:0022900) | 2.69628427 |
| 154 | inositol phosphate dephosphorylation (GO:0046855) | 2.68141435 |
| 155 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.68141435 |
| 156 | regulation of cilium movement (GO:0003352) | 2.66609585 |
| 157 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.66232948 |
| 158 | GTP biosynthetic process (GO:0006183) | 2.66144505 |
| 159 | polyol catabolic process (GO:0046174) | 2.63328499 |
| 160 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.62058328 |
| 161 | axoneme assembly (GO:0035082) | 2.61952753 |
| 162 | ketone body metabolic process (GO:1902224) | 2.61239229 |
| 163 | protein localization to mitochondrion (GO:0070585) | 2.60123185 |
| 164 | fucose catabolic process (GO:0019317) | 2.59289348 |
| 165 | L-fucose metabolic process (GO:0042354) | 2.59289348 |
| 166 | L-fucose catabolic process (GO:0042355) | 2.59289348 |
| 167 | deoxyribose phosphate catabolic process (GO:0046386) | 2.58159267 |
| 168 | platelet dense granule organization (GO:0060155) | 2.58020654 |
| 169 | DNA demethylation (GO:0080111) | 2.56729166 |
| 170 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.55841280 |
| 171 | cellular metabolic compound salvage (GO:0043094) | 2.54640035 |
| 172 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.53919158 |
| 173 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.53733531 |
| 174 | tRNA processing (GO:0008033) | 2.52354340 |
| 175 | organelle membrane fusion (GO:0090174) | 2.52111492 |
| 176 | histone H2A acetylation (GO:0043968) | 2.51673038 |
| 177 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.48339229 |
| 178 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.48339229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.52892005 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.05386890 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.96006321 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.84169506 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.49212080 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.43710403 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.34746370 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.33915004 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.07461651 |
| 10 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.93169311 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.86988789 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.86318417 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.74860988 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.69953647 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.67437157 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.58698655 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.53612891 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.48062812 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.38025851 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.25718857 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.21752898 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.17605873 |
| 23 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.16570278 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.16102514 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.15878773 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.14836252 |
| 27 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.12928557 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.12776332 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.12336533 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09969563 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.09139602 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08991126 |
| 33 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06703850 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.98619782 |
| 35 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.96522960 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90355402 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.88411148 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.79145155 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79135849 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76417736 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.75888633 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75091624 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.69991919 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68226272 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.67781764 |
| 46 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66806117 |
| 47 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.66626337 |
| 48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.65853035 |
| 49 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.64917007 |
| 50 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.62829975 |
| 51 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.61207157 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.60521639 |
| 53 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.60256947 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59333069 |
| 55 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59222763 |
| 56 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.57599944 |
| 57 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57417407 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.55625148 |
| 59 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54945409 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50648836 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48232532 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.41830343 |
| 63 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.41829717 |
| 64 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.41134182 |
| 65 | EWS_26573619_Chip-Seq_HEK293_Human | 1.40837396 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35632280 |
| 67 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34096680 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33571009 |
| 69 | AR_20517297_ChIP-Seq_VCAP_Human | 1.33430504 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33340851 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29492301 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29144940 |
| 73 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28333205 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.28096693 |
| 75 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28042864 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27251453 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24730824 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21180992 |
| 79 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20377013 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19945751 |
| 81 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14004822 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13782737 |
| 83 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11925376 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.11354094 |
| 85 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11321480 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09959637 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 1.09327737 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06460476 |
| 89 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05652176 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05437936 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04625862 |
| 92 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04042756 |
| 93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03297929 |
| 94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03297929 |
| 95 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03225958 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02892610 |
| 97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02892610 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02700018 |
| 99 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00493810 |
| 100 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99740303 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99449929 |
| 102 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99141959 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99103307 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97955151 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97935787 |
| 106 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.97751729 |
| 107 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95992721 |
| 108 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95208137 |
| 109 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95178738 |
| 110 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94745212 |
| 111 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94281593 |
| 112 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93756864 |
| 113 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93454122 |
| 114 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93113425 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92643618 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92027731 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91802567 |
| 118 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91406255 |
| 119 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89611626 |
| 120 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88278422 |
| 121 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.87725602 |
| 122 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87206649 |
| 123 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87176809 |
| 124 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87176809 |
| 125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86964189 |
| 126 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86766882 |
| 127 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.86697037 |
| 128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85881590 |
| 129 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.85843653 |
| 130 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85301492 |
| 131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84967167 |
| 132 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84652810 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84251526 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83836985 |
| 135 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83760405 |
| 136 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82537554 |
| 137 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.79098879 |
| 138 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.77416060 |
| 139 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77313271 |
| 140 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77157079 |
| 141 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.75477074 |
| 142 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.73405852 |
| 143 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.70557449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.87954503 |
| 2 | MP0010094_abnormal_chromosome_stability | 3.74688189 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.41681659 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.40048090 |
| 5 | MP0003077_abnormal_cell_cycle | 3.18283239 |
| 6 | MP0008058_abnormal_DNA_repair | 3.06594933 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.90565666 |
| 8 | MP0002102_abnormal_ear_morphology | 2.83777393 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.77409456 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.68999864 |
| 11 | MP0008057_abnormal_DNA_replication | 2.67295892 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.64118632 |
| 13 | MP0004147_increased_porphyrin_level | 2.56323958 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.39869915 |
| 15 | MP0005670_abnormal_white_adipose | 2.35381090 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26039761 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.20700252 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.15156560 |
| 19 | MP0003186_abnormal_redox_activity | 2.05589932 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.03123232 |
| 21 | MP0002163_abnormal_gland_morphology | 2.01263199 |
| 22 | MP0001529_abnormal_vocalization | 2.00852139 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 2.00513499 |
| 24 | MP0008932_abnormal_embryonic_tissue | 1.98804318 |
| 25 | MP0005410_abnormal_fertilization | 1.94798553 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.88997824 |
| 27 | MP0003786_premature_aging | 1.86615752 |
| 28 | MP0002132_abnormal_respiratory_system | 1.84758180 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.74321074 |
| 30 | MP0001984_abnormal_olfaction | 1.65681842 |
| 31 | MP0001764_abnormal_homeostasis | 1.64736246 |
| 32 | MP0003646_muscle_fatigue | 1.61361051 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.60967554 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.60967554 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.60436802 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.56574029 |
| 37 | MP0005379_endocrine/exocrine_gland_phen | 1.56085034 |
| 38 | MP0009046_muscle_twitch | 1.55802496 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.55759601 |
| 40 | MP0008789_abnormal_olfactory_epithelium | 1.55532040 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.54100315 |
| 42 | MP0003123_paternal_imprinting | 1.53544721 |
| 43 | MP0003011_delayed_dark_adaptation | 1.53091541 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.52907618 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.52236409 |
| 46 | MP0001730_embryonic_growth_arrest | 1.50384578 |
| 47 | MP0003195_calcinosis | 1.49469901 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.47706793 |
| 49 | MP0009697_abnormal_copulation | 1.47130274 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.46153839 |
| 51 | MP0003787_abnormal_imprinting | 1.45611635 |
| 52 | MP0000490_abnormal_crypts_of | 1.45022113 |
| 53 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44605297 |
| 54 | MP0008872_abnormal_physiological_respon | 1.43853223 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.43481832 |
| 56 | MP0005253_abnormal_eye_physiology | 1.42088703 |
| 57 | MP0003718_maternal_effect | 1.41769857 |
| 58 | MP0004133_heterotaxia | 1.39553548 |
| 59 | MP0000350_abnormal_cell_proliferation | 1.38334511 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.37326428 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.34603692 |
| 62 | MP0003880_abnormal_central_pattern | 1.34555240 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.34330818 |
| 64 | MP0000358_abnormal_cell_content/ | 1.33291650 |
| 65 | MP0002398_abnormal_bone_marrow | 1.31504354 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.28936071 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.28893532 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.28412712 |
| 69 | MP0001853_heart_inflammation | 1.28334871 |
| 70 | MP0005394_taste/olfaction_phenotype | 1.26760302 |
| 71 | MP0005499_abnormal_olfactory_system | 1.26760302 |
| 72 | MP0002722_abnormal_immune_system | 1.25780647 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.25610023 |
| 74 | MP0008877_abnormal_DNA_methylation | 1.24231697 |
| 75 | MP0000313_abnormal_cell_death | 1.22943083 |
| 76 | MP0002736_abnormal_nociception_after | 1.22306347 |
| 77 | MP0008995_early_reproductive_senescence | 1.19609215 |
| 78 | MP0003724_increased_susceptibility_to | 1.18578293 |
| 79 | MP0003878_abnormal_ear_physiology | 1.17852231 |
| 80 | MP0005377_hearing/vestibular/ear_phenot | 1.17852231 |
| 81 | MP0009785_altered_susceptibility_to | 1.17184298 |
| 82 | MP0002080_prenatal_lethality | 1.14799215 |
| 83 | MP0006054_spinal_hemorrhage | 1.13730642 |
| 84 | MP0005380_embryogenesis_phenotype | 1.12654101 |
| 85 | MP0001672_abnormal_embryogenesis/_devel | 1.12654101 |
| 86 | MP0010307_abnormal_tumor_latency | 1.12353235 |
| 87 | MP0005671_abnormal_response_to | 1.12025262 |
| 88 | MP0009764_decreased_sensitivity_to | 1.11202799 |
| 89 | MP0002277_abnormal_respiratory_mucosa | 1.11068858 |
| 90 | MP0002429_abnormal_blood_cell | 1.09980539 |
| 91 | MP0000015_abnormal_ear_pigmentation | 1.06752985 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 1.06697538 |
| 93 | MP0001697_abnormal_embryo_size | 1.05755760 |
| 94 | MP0002822_catalepsy | 1.05622159 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05373713 |
| 96 | MP0003984_embryonic_growth_retardation | 1.04985073 |
| 97 | MP0000703_abnormal_thymus_morphology | 1.02387770 |
| 98 | MP0002088_abnormal_embryonic_growth/wei | 1.01637741 |
| 99 | MP0002095_abnormal_skin_pigmentation | 1.01197069 |
| 100 | MP0005266_abnormal_metabolism | 0.99053274 |
| 101 | MP0002928_abnormal_bile_duct | 0.99020259 |
| 102 | MP0002160_abnormal_reproductive_system | 0.98718725 |
| 103 | MP0003698_abnormal_male_reproductive | 0.97778502 |
| 104 | MP0002210_abnormal_sex_determination | 0.97530993 |
| 105 | MP0002139_abnormal_hepatobiliary_system | 0.95938544 |
| 106 | MP0002970_abnormal_white_adipose | 0.95386153 |
| 107 | MP0000858_altered_metastatic_potential | 0.94971211 |
| 108 | MP0004084_abnormal_cardiac_muscle | 0.94722245 |
| 109 | MP0000716_abnormal_immune_system | 0.94082854 |
| 110 | MP0000647_abnormal_sebaceous_gland | 0.93030013 |
| 111 | MP0001905_abnormal_dopamine_level | 0.92587879 |
| 112 | MP0008260_abnormal_autophagy | 0.91042995 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.90779636 |
| 114 | MP0004924_abnormal_behavior | 0.90779636 |
| 115 | MP0002090_abnormal_vision | 0.90335380 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.89216432 |
| 117 | MP0000685_abnormal_immune_system | 0.88290120 |
| 118 | MP0005085_abnormal_gallbladder_physiolo | 0.87396936 |
| 119 | MP0005636_abnormal_mineral_homeostasis | 0.86741360 |
| 120 | MP0004142_abnormal_muscle_tone | 0.86168663 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.85950441 |
| 122 | MP0000427_abnormal_hair_cycle | 0.85406245 |
| 123 | MP0005389_reproductive_system_phenotype | 0.85300114 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.85200610 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.84358793 |
| 126 | MP0000343_altered_response_to | 0.84013468 |
| 127 | MP0008873_increased_physiological_sensi | 0.82020543 |
| 128 | MP0002938_white_spotting | 0.81785121 |
| 129 | MP0001929_abnormal_gametogenesis | 0.81730770 |
| 130 | MP0002420_abnormal_adaptive_immunity | 0.81693507 |
| 131 | MP0001800_abnormal_humoral_immune | 0.81594729 |
| 132 | MP0003315_abnormal_perineum_morphology | 0.81535646 |
| 133 | MP0003436_decreased_susceptibility_to | 0.81054795 |
| 134 | MP0000516_abnormal_urinary_system | 0.80882032 |
| 135 | MP0005367_renal/urinary_system_phenotyp | 0.80882032 |
| 136 | MP0001145_abnormal_male_reproductive | 0.80775843 |
| 137 | MP0002229_neurodegeneration | 0.80696056 |
| 138 | MP0000598_abnormal_liver_morphology | 0.79957833 |
| 139 | MP0000749_muscle_degeneration | 0.79531019 |
| 140 | MP0001819_abnormal_immune_cell | 0.79529825 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.78811682 |
| 142 | MP0005025_abnormal_response_to | 0.78512026 |
| 143 | MP0010386_abnormal_urinary_bladder | 0.78001782 |
| 144 | MP0004130_abnormal_muscle_cell | 0.77955579 |
| 145 | MP0009840_abnormal_foam_cell | 0.77070072 |
| 146 | MP0000653_abnormal_sex_gland | 0.75120496 |
| 147 | MP0009745_abnormal_behavioral_response | 0.74265828 |
| 148 | MP0000613_abnormal_salivary_gland | 0.73891353 |
| 149 | MP0005330_cardiomyopathy | 0.73837747 |
| 150 | MP0004043_abnormal_pH_regulation | 0.73717970 |
| 151 | MP0002166_altered_tumor_susceptibility | 0.73665564 |
| 152 | MP0000609_abnormal_liver_physiology | 0.73664939 |
| 153 | MP0002723_abnormal_immune_serum | 0.71630333 |
| 154 | MP0002148_abnormal_hypersensitivity_rea | 0.71598437 |
| 155 | MP0002269_muscular_atrophy | 0.71353021 |
| 156 | MP0008469_abnormal_protein_level | 0.71187440 |
| 157 | MP0002452_abnormal_antigen_presenting | 0.70356146 |
| 158 | MP0005332_abnormal_amino_acid | 0.69836257 |
| 159 | MP0000750_abnormal_muscle_regeneration | 0.69544899 |
| 160 | MP0002086_abnormal_extraembryonic_tissu | 0.67149559 |
| 161 | MP0000465_gastrointestinal_hemorrhage | 0.66980802 |
| 162 | MP0005174_abnormal_tail_pigmentation | 0.66572304 |
| 163 | MP0001119_abnormal_female_reproductive | 0.66211518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.14235422 |
| 2 | Hepatic necrosis (HP:0002605) | 3.99689327 |
| 3 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.96463773 |
| 4 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.96463773 |
| 5 | Hepatocellular necrosis (HP:0001404) | 3.64597355 |
| 6 | Aplastic anemia (HP:0001915) | 3.62596491 |
| 7 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.54784665 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 3.45194820 |
| 9 | Pancreatic cysts (HP:0001737) | 3.44373131 |
| 10 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.41828063 |
| 11 | Abnormality of alanine metabolism (HP:0010916) | 3.41828063 |
| 12 | Hyperalaninemia (HP:0003348) | 3.41828063 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.36812310 |
| 14 | Reticulocytopenia (HP:0001896) | 3.28641189 |
| 15 | * Increased serum lactate (HP:0002151) | 3.25564999 |
| 16 | Increased CSF lactate (HP:0002490) | 3.11545572 |
| 17 | Pancreatic fibrosis (HP:0100732) | 3.11201129 |
| 18 | Type I transferrin isoform profile (HP:0003642) | 3.10728100 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.07125745 |
| 20 | Acute necrotizing encephalopathy (HP:0006965) | 3.04967750 |
| 21 | Mitochondrial inheritance (HP:0001427) | 2.98549201 |
| 22 | * Lactic acidosis (HP:0003128) | 2.97358368 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 2.95930474 |
| 24 | Rhabdomyolysis (HP:0003201) | 2.93544048 |
| 25 | True hermaphroditism (HP:0010459) | 2.92985592 |
| 26 | Breast hypoplasia (HP:0003187) | 2.92087919 |
| 27 | Increased muscle lipid content (HP:0009058) | 2.90586070 |
| 28 | Oral leukoplakia (HP:0002745) | 2.88659836 |
| 29 | Acute encephalopathy (HP:0006846) | 2.80858220 |
| 30 | Medial flaring of the eyebrow (HP:0010747) | 2.79665784 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 2.79647008 |
| 32 | Abnormality of midbrain morphology (HP:0002418) | 2.79647008 |
| 33 | Abnormality of the anterior horn cell (HP:0006802) | 2.76769970 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 2.76769970 |
| 35 | Nausea (HP:0002018) | 2.74768091 |
| 36 | Increased serum pyruvate (HP:0003542) | 2.73477852 |
| 37 | Abnormality of glycolysis (HP:0004366) | 2.73477852 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.71861931 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.71861931 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 2.71861931 |
| 41 | Abnormal glycosylation (HP:0012345) | 2.71861931 |
| 42 | Type II lissencephaly (HP:0007260) | 2.69303135 |
| 43 | Multiple enchondromatosis (HP:0005701) | 2.68972215 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.68428173 |
| 45 | Bile duct proliferation (HP:0001408) | 2.68165717 |
| 46 | Abnormal biliary tract physiology (HP:0012439) | 2.68165717 |
| 47 | Ketosis (HP:0001946) | 2.67953026 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66083010 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.66083010 |
| 50 | Thrombocytosis (HP:0001894) | 2.65456241 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.63074807 |
| 52 | Pancytopenia (HP:0001876) | 2.59737454 |
| 53 | Microretrognathia (HP:0000308) | 2.59226187 |
| 54 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58998285 |
| 55 | Hyperglycinuria (HP:0003108) | 2.55099834 |
| 56 | Exercise intolerance (HP:0003546) | 2.54625869 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.54547777 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.52494748 |
| 59 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.50548399 |
| 60 | Methylmalonic aciduria (HP:0012120) | 2.49783523 |
| 61 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49309844 |
| 62 | Type 2 muscle fiber atrophy (HP:0003554) | 2.49054377 |
| 63 | Ketoacidosis (HP:0001993) | 2.48424357 |
| 64 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.46562253 |
| 65 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.45101344 |
| 66 | Colon cancer (HP:0003003) | 2.41631890 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.41564637 |
| 68 | Cerebral hypomyelination (HP:0006808) | 2.40964832 |
| 69 | Nephronophthisis (HP:0000090) | 2.39838580 |
| 70 | Retinal dysplasia (HP:0007973) | 2.35716045 |
| 71 | Muscle fiber atrophy (HP:0100295) | 2.35694404 |
| 72 | Progressive macrocephaly (HP:0004481) | 2.35514001 |
| 73 | Macrocytic anemia (HP:0001972) | 2.32808033 |
| 74 | Congenital stationary night blindness (HP:0007642) | 2.32017147 |
| 75 | Rough bone trabeculation (HP:0100670) | 2.30024643 |
| 76 | Increased hepatocellular lipid droplets (HP:0006565) | 2.29740154 |
| 77 | Progressive microcephaly (HP:0000253) | 2.29541809 |
| 78 | Proximal tubulopathy (HP:0000114) | 2.27472143 |
| 79 | Hyperglycinemia (HP:0002154) | 2.26502286 |
| 80 | Renal Fanconi syndrome (HP:0001994) | 2.26139229 |
| 81 | Cerebral edema (HP:0002181) | 2.25984116 |
| 82 | Selective tooth agenesis (HP:0001592) | 2.21985833 |
| 83 | Methylmalonic acidemia (HP:0002912) | 2.21838969 |
| 84 | Respiratory difficulties (HP:0002880) | 2.20783348 |
| 85 | Optic disc pallor (HP:0000543) | 2.19908823 |
| 86 | Progressive inability to walk (HP:0002505) | 2.19192488 |
| 87 | Nephrogenic diabetes insipidus (HP:0009806) | 2.17505519 |
| 88 | Lethargy (HP:0001254) | 2.17503180 |
| 89 | CNS demyelination (HP:0007305) | 2.17150637 |
| 90 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.16217712 |
| 91 | Abnormality of glycine metabolism (HP:0010895) | 2.16217712 |
| 92 | Patellar aplasia (HP:0006443) | 2.15544817 |
| 93 | Abnormality of the renal cortex (HP:0011035) | 2.14852708 |
| 94 | Pallor (HP:0000980) | 2.14086371 |
| 95 | IgM deficiency (HP:0002850) | 2.12423114 |
| 96 | Premature graying of hair (HP:0002216) | 2.12377800 |
| 97 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12004228 |
| 98 | Megaloblastic anemia (HP:0001889) | 2.11449435 |
| 99 | Congenital primary aphakia (HP:0007707) | 2.11344376 |
| 100 | Renal cortical cysts (HP:0000803) | 2.10360108 |
| 101 | Respiratory failure (HP:0002878) | 2.10347768 |
| 102 | Exertional dyspnea (HP:0002875) | 2.09688817 |
| 103 | Opisthotonus (HP:0002179) | 2.08969481 |
| 104 | Chromsome breakage (HP:0040012) | 2.07259413 |
| 105 | Hypothermia (HP:0002045) | 2.06607340 |
| 106 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06547230 |
| 107 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.03540577 |
| 108 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.02858744 |
| 109 | Abnormal spermatogenesis (HP:0008669) | 2.02817367 |
| 110 | Bone marrow hypocellularity (HP:0005528) | 2.02705238 |
| 111 | Chronic hepatic failure (HP:0100626) | 2.02561242 |
| 112 | Absent thumb (HP:0009777) | 2.02332254 |
| 113 | Attenuation of retinal blood vessels (HP:0007843) | 2.02180519 |
| 114 | Delusions (HP:0000746) | 2.02133576 |
| 115 | Gait imbalance (HP:0002141) | 2.02075487 |
| 116 | Petechiae (HP:0000967) | 2.01750941 |
| 117 | Myelodysplasia (HP:0002863) | 2.01410051 |
| 118 | Abnormality of the preputium (HP:0100587) | 2.01059674 |
| 119 | Abnormality of chromosome stability (HP:0003220) | 1.99865739 |
| 120 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.97930327 |
| 121 | Myoglobinuria (HP:0002913) | 1.96762317 |
| 122 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.96435666 |
| 123 | Agnosia (HP:0010524) | 1.96036363 |
| 124 | Microvesicular hepatic steatosis (HP:0001414) | 1.95196320 |
| 125 | Meckel diverticulum (HP:0002245) | 1.95189184 |
| 126 | Focal motor seizures (HP:0011153) | 1.94892209 |
| 127 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.94010830 |
| 128 | 11 pairs of ribs (HP:0000878) | 1.93399144 |
| 129 | Occipital encephalocele (HP:0002085) | 1.92804779 |
| 130 | Agammaglobulinemia (HP:0004432) | 1.92749282 |
| 131 | Cellular immunodeficiency (HP:0005374) | 1.92672027 |
| 132 | Abnormality of the renal medulla (HP:0100957) | 1.92189079 |
| 133 | Progressive muscle weakness (HP:0003323) | 1.91953763 |
| 134 | Carpal bone hypoplasia (HP:0001498) | 1.90510389 |
| 135 | Emotional lability (HP:0000712) | 1.90273762 |
| 136 | Abnormality of the ileum (HP:0001549) | 1.89975892 |
| 137 | Abnormality of the renal collecting system (HP:0004742) | 1.89413833 |
| 138 | Vacuolated lymphocytes (HP:0001922) | 1.88439805 |
| 139 | Sparse eyelashes (HP:0000653) | 1.87681085 |
| 140 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.87360640 |
| 141 | Cystic liver disease (HP:0006706) | 1.86509024 |
| 142 | Hypoglycemic coma (HP:0001325) | 1.85724338 |
| 143 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.84744924 |
| 144 | Cerebral palsy (HP:0100021) | 1.84433338 |
| 145 | Sclerocornea (HP:0000647) | 1.84289480 |
| 146 | Abnormality of lateral ventricle (HP:0030047) | 1.80294894 |
| 147 | Lissencephaly (HP:0001339) | 1.80242585 |
| 148 | Stomatitis (HP:0010280) | 1.80173131 |
| 149 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79035741 |
| 150 | Absent/shortened dynein arms (HP:0200106) | 1.79035741 |
| 151 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78099716 |
| 152 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.77363152 |
| 153 | Inability to walk (HP:0002540) | 1.75496388 |
| 154 | Abnormality of macular pigmentation (HP:0008002) | 1.75317176 |
| 155 | Abnormality of the labia minora (HP:0012880) | 1.71269009 |
| 156 | Severe visual impairment (HP:0001141) | 1.71068764 |
| 157 | Congenital hepatic fibrosis (HP:0002612) | 1.70199846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 4.45935098 |
| 2 | BUB1 | 4.42733018 |
| 3 | WEE1 | 3.67573356 |
| 4 | PLK4 | 3.27886913 |
| 5 | EIF2AK1 | 3.26237753 |
| 6 | STK16 | 3.04341116 |
| 7 | VRK2 | 2.88230268 |
| 8 | BCKDK | 2.70050412 |
| 9 | NME2 | 2.61752256 |
| 10 | TAOK3 | 2.54449327 |
| 11 | NUAK1 | 2.54021396 |
| 12 | BMPR1B | 2.53255150 |
| 13 | FRK | 2.48583797 |
| 14 | ACVR1B | 2.46333399 |
| 15 | TSSK6 | 2.39496951 |
| 16 | VRK1 | 2.19109445 |
| 17 | BRSK2 | 2.11257080 |
| 18 | ZAK | 2.06631240 |
| 19 | EIF2AK3 | 2.06417910 |
| 20 | PDK4 | 2.02465367 |
| 21 | PDK3 | 2.02465367 |
| 22 | WNK3 | 2.01970068 |
| 23 | TRIM28 | 1.96039984 |
| 24 | CDC7 | 1.92470726 |
| 25 | SRPK1 | 1.90615874 |
| 26 | NEK1 | 1.89417384 |
| 27 | PIM2 | 1.79139914 |
| 28 | CCNB1 | 1.66841565 |
| 29 | ADRBK2 | 1.61424044 |
| 30 | TESK2 | 1.60558214 |
| 31 | MAPK13 | 1.58567385 |
| 32 | INSRR | 1.56672914 |
| 33 | FLT3 | 1.54551835 |
| 34 | GRK1 | 1.50611414 |
| 35 | TGFBR1 | 1.49764932 |
| 36 | TTK | 1.48973898 |
| 37 | PLK1 | 1.46121322 |
| 38 | BRSK1 | 1.40560159 |
| 39 | PASK | 1.40362484 |
| 40 | NEK2 | 1.37055789 |
| 41 | CSNK1G3 | 1.35555576 |
| 42 | MAP2K3 | 1.35120167 |
| 43 | TLK1 | 1.29990625 |
| 44 | ATR | 1.29399631 |
| 45 | TESK1 | 1.28942877 |
| 46 | PLK3 | 1.23504097 |
| 47 | TAOK2 | 1.21060140 |
| 48 | DYRK3 | 1.20913339 |
| 49 | RPS6KB2 | 1.20230695 |
| 50 | CDK7 | 1.18712556 |
| 51 | CSNK1A1L | 1.16953477 |
| 52 | PDK2 | 1.15645059 |
| 53 | MKNK1 | 1.13197631 |
| 54 | AURKB | 1.12844734 |
| 55 | RPS6KA4 | 1.10635508 |
| 56 | ERBB3 | 1.09417970 |
| 57 | MAP3K4 | 1.06411203 |
| 58 | KDR | 1.05671389 |
| 59 | CSNK1G1 | 1.05136405 |
| 60 | MAPKAPK3 | 1.02676753 |
| 61 | BCR | 0.98758073 |
| 62 | EIF2AK2 | 0.97280143 |
| 63 | CDK4 | 0.97193387 |
| 64 | TNK2 | 0.96365487 |
| 65 | CDK19 | 0.92826420 |
| 66 | KIT | 0.92634016 |
| 67 | TAOK1 | 0.91987252 |
| 68 | IRAK3 | 0.90890686 |
| 69 | CSNK1G2 | 0.89999408 |
| 70 | ZAP70 | 0.86966511 |
| 71 | AURKA | 0.86438620 |
| 72 | BLK | 0.83888007 |
| 73 | LMTK2 | 0.83700770 |
| 74 | SCYL2 | 0.80218086 |
| 75 | PIM1 | 0.80008566 |
| 76 | MAP3K3 | 0.79426959 |
| 77 | CDK8 | 0.79290804 |
| 78 | CAMKK2 | 0.79091150 |
| 79 | NEK9 | 0.79018509 |
| 80 | MYLK | 0.78933422 |
| 81 | NME1 | 0.77575102 |
| 82 | CHEK2 | 0.74585537 |
| 83 | FES | 0.74010424 |
| 84 | MKNK2 | 0.73402977 |
| 85 | WNK4 | 0.72820121 |
| 86 | MAP3K11 | 0.72415765 |
| 87 | TEC | 0.72330014 |
| 88 | MAP4K1 | 0.72292073 |
| 89 | TXK | 0.71216219 |
| 90 | STK10 | 0.70501485 |
| 91 | MAP3K8 | 0.68205043 |
| 92 | BTK | 0.67609806 |
| 93 | CSNK2A1 | 0.66860315 |
| 94 | LYN | 0.66560009 |
| 95 | TGFBR2 | 0.64722931 |
| 96 | ITK | 0.64613719 |
| 97 | STK38L | 0.61644077 |
| 98 | BRAF | 0.61354843 |
| 99 | MAP2K7 | 0.60679251 |
| 100 | IRAK4 | 0.59705894 |
| 101 | MAPKAPK5 | 0.59154935 |
| 102 | GRK6 | 0.58641347 |
| 103 | BMPR2 | 0.58612966 |
| 104 | EPHA4 | 0.58506768 |
| 105 | MAP3K5 | 0.58447902 |
| 106 | CHEK1 | 0.58270787 |
| 107 | STK4 | 0.57610591 |
| 108 | GRK7 | 0.57604412 |
| 109 | CASK | 0.57075303 |
| 110 | TYK2 | 0.56960573 |
| 111 | PHKG2 | 0.56461682 |
| 112 | PHKG1 | 0.56461682 |
| 113 | MATK | 0.54813927 |
| 114 | PBK | 0.54123455 |
| 115 | PAK4 | 0.53656400 |
| 116 | PLK2 | 0.53573308 |
| 117 | AKT3 | 0.52566586 |
| 118 | IKBKB | 0.52020366 |
| 119 | DAPK1 | 0.51917689 |
| 120 | CSNK2A2 | 0.50248312 |
| 121 | YES1 | 0.49694839 |
| 122 | STK24 | 0.49621095 |
| 123 | EEF2K | 0.48946116 |
| 124 | PRKCQ | 0.47708826 |
| 125 | RPS6KB1 | 0.46780585 |
| 126 | ABL2 | 0.46649842 |
| 127 | OBSCN | 0.46554248 |
| 128 | CSF1R | 0.46350199 |
| 129 | MAP3K12 | 0.45578812 |
| 130 | SYK | 0.45520074 |
| 131 | TBK1 | 0.44307866 |
| 132 | MST4 | 0.44270770 |
| 133 | MAPK11 | 0.43758489 |
| 134 | CDK3 | 0.42200814 |
| 135 | MARK3 | 0.42100167 |
| 136 | TNIK | 0.42022084 |
| 137 | CSNK1A1 | 0.41157214 |
| 138 | PRKCE | 0.40597919 |
| 139 | ATM | 0.40462735 |
| 140 | RPS6KC1 | 0.40447721 |
| 141 | RPS6KL1 | 0.40447721 |
| 142 | ABL1 | 0.39395265 |
| 143 | PRKACB | 0.39306786 |
| 144 | MAP2K6 | 0.38315795 |
| 145 | DYRK2 | 0.38149798 |
| 146 | PRKCI | 0.37624601 |
| 147 | RPS6KA6 | 0.37409276 |
| 148 | ILK | 0.37401380 |
| 149 | PKN2 | 0.37380213 |
| 150 | JAK3 | 0.37049928 |
| 151 | RPS6KA5 | 0.36931358 |
| 152 | ADRBK1 | 0.36466929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.32736522 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.65924186 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.38687659 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.20277756 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.02609045 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.78906640 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.76368930 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.67230698 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.64061063 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.56828008 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.43762796 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.38832031 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.31542807 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.22834976 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.19849265 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.14834979 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01052394 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.96624412 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 1.82332643 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81601175 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.77230078 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.71319053 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.63437966 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56867227 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55432727 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54564717 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53054343 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.51284473 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.49792604 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47614646 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47403198 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45490161 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.44762944 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.43764916 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.43513904 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.41251766 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38033748 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33023745 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31718665 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30248148 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29404082 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.28104274 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26594741 |
| 44 | Protein export_Homo sapiens_hsa03060 | 1.25470726 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24707134 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22795369 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19834020 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17721952 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16579321 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14233143 |
| 51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10649573 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.10600011 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06777611 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04544067 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04143143 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02627803 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99807243 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99324914 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98784701 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97644758 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95731541 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92036555 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90458507 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.90304741 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88235484 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85915877 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85297410 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83569270 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82299190 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79440817 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76856459 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74488752 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73059662 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73037397 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72700221 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72251599 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72087784 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71770338 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.70742175 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69762580 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68948293 |
| 82 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68861978 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67230189 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66486283 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66161962 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64560350 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64250873 |
| 88 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62367603 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61587818 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.60988687 |
| 91 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57931714 |
| 92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57924900 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55676422 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55183604 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54064889 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53778421 |
| 97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51344439 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50952200 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49055695 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48962055 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47341348 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.47093995 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46993617 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46724398 |
| 105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45650406 |
| 106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45416148 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43248752 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43232111 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43190025 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41461050 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39618622 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39161922 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36269189 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.34778194 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30943819 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30754938 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27848410 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26739818 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26012062 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.26007456 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.25605128 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25020223 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23364915 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.22518079 |
| 125 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.21790096 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.21454900 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21228954 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.21149081 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20708198 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.15607810 |
| 131 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.14724212 |
| 132 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.13889513 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13607095 |
| 134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.12157193 |
| 135 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.10909725 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.10364071 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.10111948 |

